PMID: 19137768Jan 14, 2009Paper

Subantimicrobial-dose doxycycline in the treatment of moderate facial acne

Journal of Drugs in Dermatology : JDD
Parviz ToossiArash Kimyai-Asadi

Abstract

Acne is a common inflammatory skin disorder. Oral antibiotics play a significant clinical role in treating acne. The purpose of this study was to compare the efficacy of doxycycline at antimicrobial and subantimicrobial doses for the treatment of acne. A prospective, randomized, double-blind, controlled trial was performed. One hundred patients with moderate facial acne were randomized into 2 treatment groups, one receiving a tablet containing 20 mg of doxycycline to be taken twice daily and the other receiving a tablet containing 100 mg of doxycycline and a matching placebo tablet to be taken twice daily. Subantimicrobial-dose doxycycline administered twice daily for 3 months in patients with moderate inflammatory acne results in significant reduction in the number of total inflammatory lesions. There was an 84% reduction in number of papules and a 90% reduction in number of pustules with treatment. Subantimicrobial-dose doxycycline is an effective treatment for patients with moderate acne vulgaris.

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of the American Academy of Dermatology
Alison Layton, Diane Thiboutot
P & T : a Peer-reviewed Journal for Formulary Management
Brittney Culp, Noah Scheinfeld
© 2021 Meta ULC. All rights reserved